Innovative Approaches in Nephrology, Endocrinology, and Antimicrobial Resistance

This chapter covers APO-L1 mediated kidney disease, the promising drug anaxipline, and the advantages of using cystatin C in estimating EGFR. It also touches on testosterone replacement therapy, focusing on different formulations and physical exam findings, as well as antimicrobial resistance, highlighting MRSA infections and insights on antibiotic testing. The chapter emphasizes targeted lab testing and strategies for de-labeling patients with penicillin allergies, along with safety protocols for conducting an oral amoxicillin challenge.